期刊文献+

巨细胞病毒感染细胞的免疫原性分析 被引量:3

Immunogenecity of cytomegalovirus-infected fibroblasts
下载PDF
导出
摘要 目的:检测细胞感染巨细胞病毒后诱导免疫应答的能力。方法:将巨细胞病毒感染人胚肺成纤维母细胞(HELF),抗体标记细胞表面HLA-A2分子,流式细胞术(FCM)检测感染细胞HLA-A02表达强度;将感染的HELF、荷载外源性多肽的自身PBMC以及未感染的HELF,分别与PBMC共同孵育,FCM检测CD8+T细胞内IFN-γ的表达作为应答指标。结果:感染细胞HLA-A分子表达强度较未感染组降低78.24%±19.72%。感染并荷载外源性多肽的HELF诱导产生的刺激应答率,高于单纯巨细胞病毒感染的HELF和荷载多肽的未感染HELF所诱导应答比率。结论:尽管巨细胞病毒下调MHCI分子表达,但可能不减弱细胞递呈外源多肽的能力,并足以诱导产生免疫应答。 AIM: To analyze the capability of cytomegalovirus (CMV)-infected human embryonic lung fibroblasts (HELFs) to induce immune response. METHODS: HELFs were infected with cytomegalovirus and stained with antibody against HLA-A2 molecular, the expression of HLA-A2 was detected by FCM. The infected HELFs were incubated with individual pp65 peptide NLVPMVATV. While the uninfected and unloaded infected HELFs served as control respectively. After PBMC was added to the differently treated HELFs and incubated, the immune response was measured with IFN-γ release as readout. RESULTS: The expression of HLA-A molecular on infected fibroblasts diminished markedly compared with that on the uninfected. The peptides expressed on the infected HELFs together with those pulsed externally induced a stronger response than the infected HELFs alone. CONCLUSION: Although CMV can downregulate the expression of MHC Ⅰ on the infected cells, it can not decrease the capacity of cells to present peptides loaded externally, and therefore still induce immune response to some extent.
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2009年第10期907-909,913,共4页 Chinese Journal of Cellular and Molecular Immunology
基金 教育部留学归国人员科研启动基金(教外司留(2008)101号) 北京市优秀人才培养资助个人项目(20081D0301600099)
关键词 巨细胞病毒 特异性免疫应答 免疫原性 抗原递呈 移植 cytomegalovirus specific immune response immunogenecity antigen presentation transplantation
  • 相关文献

参考文献10

  • 1Widmann T, Sester U, Gartner BC, et al. Levels of CMV Specific CD4 T Ceils Are Dynamic and Correlate with CMV Viremia after Allogeneic Stem Cell Transplantation[ J ]. PLoS ONE, 2008, 3 (11 ) : e363g.
  • 2Hakki M, Riddell SR, Storek J, et al. Immune reconstitution to cytomegalovirus after allogeneic hematopoietic stem cell transplantation: impact of host factors, drug therapy, and subclinical reactivation[ J]. Blood, 2003, 102(8): 3060-3067.
  • 3Ljungman P. CMV infections after hematopoietic stem cell transplantation. Bone Marrow Transplant [ J ]. Bone Marrow Transplant, 2008, 42 ( Suppl1 ) : 70 - 72.
  • 4Ljungman P. Risk assessment in haematopoietic stem cell transplantation: viral status[ J]. Best Pract Res Clin Haematol, 2007, 20 (2) : 209 - 217.
  • 5Ganepola S, Gentilini C, Hilbers U, et al. Patients at high risk for CMV infection and disease show delayed CD8^+ T-cell immune recovery after allogeneic stem cell transplantation [J]. Bone Marrow Transplant, 2007, 39(5): 293-299.
  • 6Basta S, Bennink JR. A survival game of hide and seek : cytomegalov iruses and MHC class I antigen presentation pathways [ J ]. Viral Immunol, 2003, 16(3) : 231 -242.
  • 7Zhao Y, Biegalke BJ. Functional analysis of the human cytomegalovirus immune evasion protein, pUS3 (22kDa) [ J]. Virology, 2003,315 (2) : 353 -361.
  • 8Park B, Kim Y, Shin J, et al. Human cytomegalovirus inhibits tapasin-dependent peptide loading and optimization of the MHC class I peptide cargo for immune evasion[J]. Immunity, 2004, 20(1 ): 71 - 85.
  • 9Slifka MK, Whitton JL. Functional avidity maturation of CD8 ( + ) T cells without selection of higher affinity TCR [J]. Nat lmmunol, 2001, 2(8) : 711 -717.
  • 10Voo KS, Fu T, Wang HY, et al. Evidence for the presentation of major histocompatibility complex class I-restricted Epstein-Barr virus nuclear antigen 1 peptides to CD8 ^+ T lymphocytes[ J]. J Exp Med, 2004, 199(4) : 459 -470.

同被引文献18

引证文献3

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部